ArticleJournal for immunotherapy of cancer2024
Correction: Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.